HAO haoximedia.com: מכפיל מחיר להכנסות עתידי

Haoxi Health Technology is implementing eco-friendly cloud solutions and strict data controls within medical advertising. The forward price-to-sales valuation reflects market expectations, with the metric currently standing at 0.00. While financial success is driven by Chinese wellness budgets, reliance on a narrow circle of e-commerce partners and content censorship creates risks of revenue volatility.

Forward P/S relates current market capitalization to expected sales, reflecting the market rate per unit of future revenue amid shifting costs. The stability of this metric confirms the resilience of Haoxi Health Technology (HAO), whose diversification across independent medical clinics and pharmaceutical brands mitigates regulatory risks, as clearly evidenced by the forward price-to-sales valuation trend.